Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Neuhaus, O; Strasser-Fuchs, S; Fazekas, F; Kieseier, BC; Niederwieser, G; Hartung, HP; Archelos, JJ.
Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Neurology. 2002; 59(7):990-997
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Archelos-Garcia Juan-Jose
Fazekas Franz
Fuchs Siegrid

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

BACKGROUND: Recent data suggest that statins may be potent immunomodulatory agents. In order to evaluate the potential role of statins as immunomodulators in MS, the authors studied their immunologic effects in vitro and compared them to interferon (IFN)beta-1b. METHODS: Peripheral blood mononuclear cells (PBMC) obtained from untreated or IFN beta-1-treated patients with relapsing-remitting MS or from healthy donors (HD) and T cells were stimulated with concanavalin A, phytohemagglutinin, or antibody to CD3 in the presence of lovastatin, simvastatin, mevastatin, IFN beta-1b, or statins plus IFN beta-1b. The authors analyzed proliferative activity of T cells and B cells, cytokine production and release, activity of matrix metalloproteinases (MMP), and surface expression of activation markers, adhesion molecules, and chemokine receptors on both T and B cells. RESULTS: All three statins inhibited proliferation of stimulated PBMC in a dose-dependent manner, with simvastatin being the most potent, followed by lovastatin and mevastatin. IFN beta-1b showed a similar effect; statins and IFN beta-1b together added their inhibitory potentials. Furthermore, statins reduced the expression of activation-induced adhesion molecules on T cells, modified the T helper 1/T helper 2 cytokine balance, reduced MMP-9, and downregulated chemokine receptors on both B and T cells. Besides strong anti-inflammatory properties, statins also exhibited some proinflammatory effects. CONCLUSIONS: Statins are effective immunomodulators in vitro that merit evaluation as treatment for MS.
Find related publications in this database (using NLM MeSH Indexing)
Adjuvants, Immunologic - pharmacology
B-Lymphocytes - drug effects
Cell Division - drug effects
Dose-Response Relationship, Drug - drug effects
Humans - drug effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology
Interferon-beta - pharmacology
Leukocytes, Mononuclear - drug effects
Multiple Sclerosis, Relapsing-Remitting - drug therapy
Receptors, Chemokine - immunology
Statistics, Nonparametric - immunology
T-Lymphocytes - drug effects

© Med Uni Graz Impressum